Ekspresi Pulasan Imunohistokimia Rantes Pada Jaringan Endometriosis Di RSUP H.Adam Malik Medan

54

DAFTAR PUSTAKA

1. Schorge JO, Schaffer JI, Halvorson LM, Endometriosis. 2 Ed.section

1.Chapter 10.Williams Gynecology. McGraw-Hill’s. 2008 :281
2. C

Jessi. Pemeriksaan imunohistokimia CD 10 dibandingkan dengan

pemeriksaan mikroskopis histopatologi konvensional dalam menilai jenis kista
coklat ovarium di laboratorium Patologi Anatomi FK usu Medan.2012;1.
3. Jacoeb TZ, Hadisaputra W. Penanganan Endometriosis:Panduan Klinis Dan

Algoritme.Sagung Seto Jakarta 2009;2-5
4. Wang XQ,Yu Jing, Luo XZ,Shi YL, Wang Yun,Wang Ling, Li DJ. The high

level of RANTES in the ectopic milieu recruits macrophages and induces their
tolerance in progression of endometriosis.J Endometriosis. Molecular
endocrinology 2011;291-299.

5. Garai J,Molnar V,Varga T,Koppan M, Torok Attila,Bodis J. Endometriosis:

harmful survival of an ectopic tissue.

Frontiers in Bioscience 11, Januari

1,2006;595-619
6. Hacker FN. Essentials of Obstetrics and Gynecology.5th edition.2010
7. A sante, Taylor RN. Endometriosis: The Role of Neuroangiogenesis.

Departemen of Gynecology and Obstetrics. Emory University School of
Medicine. Atlanta Georgia. 2010;163-177
8. Winata IGS, Suwiyoga K. Hubungan Cadangan Ovarium, AFC, AMH pada

Kasus Endometriosis. Divisi Onkologi Ginekologi, FK UNUD/ RSUP Sanglah
Denpasar.2013;6-8

Universitas Sumatera Utara

Universitas Sumatera Utara

55
9. D Hooghe TM, Hill JA. Endometriosis. In : Berek JS editor. Novak’s

Gynecology. 13th edition.Philadelphia:Lippincott Williams & Wilkins. 2010;93159.
10.Baziad Ali.Endokrinologi Ginekologi: Endometriosis. Edisi ketiga. Penerbit
Media Aesculapius Fakultas Kedokteran Universitas Indonesia. Jakarta: 2008
11.Speroff L., Fritz A.M. Clinical Gynecologic Endocrinology and Infertility:
Endometriosis. 7th edition. Lippincott Williams & Wilkins. North Caroline: 2005.
12.Depalo R, Cavallini A, Lorusso F, Bassi E, Totaro I, Marzullo A, Bettocchi S,
Selvaggi L. Apoptosis in normal ovaries of women with and without
endometriosis. Reproductive BioMedicine Online. 19 (6) : 808–15 Available at:
www.rbmonline.com/Article/4115 on web 30 September 2009.
13. Luigi E.S. Apoptosis in Normal Ovaries of Woman With and Without
Endometriosis. Reproductive BioMedicine Online. 2009; 19 (6):808-15.
14. L.L.P. Hii and P.A.W. Rogers. Endometrial Vascular and Glandular
Expression of Integrin αVβ3 in Women With and Without Endometriosis. Hum
Reprod. 1998; 13 (4): 1030-5.
15. Hornung D, Bentzien F, Wallwiener D kiesel L Taylor R.N. Chemokine
bioativity of RANTES in endometriotic and normal endometrial stromal cells

and peritoneal fluid. Molecular Human Reproduction,2001 Vol 7 No.2 163168.
16. Hanna A. And Ariel R. Endometrial Receptivity Markers, The Journey to
Succesful Embryo Implantation. Hum Reprod. 2006; 12 (6):731-46.
17. Tsudo T,Harada T,Iwabe T, Tanikawa M,Nagano Y Ito M.Altered gene
expression and secretion of interleukin -6 in stromal cells derived from
endometriotic tissue fertil steril 2000,Feb 205-11

Universitas Sumatera Utara

Universitas Sumatera Utara

56

18. Vinatier D,Orazi G,Cosson M,Dufour P.Theories of endometriosis,Eur J
obstet Gynecol Reprod Biol 2001.96(1)21-39
19. Hornung D,Isabelle P Ryan,Victor A,chao Jean LV,Schriock ED,Taylor RN.
Immunolocolization and Regulation of the Chemokine RANTES in Human
Endometrial and Endometriosis Tissue and cells.2013.
20. Bernardi LA, Pavone ME. Infertility. Endometriosis. Women’s Health,
2013;9(3):233-250

21. Jacoeb TZ, Hadisaputra W. Penanganan Endometriosis. Panduan Klinis dan
Algoritme. Sagung Seto, Jakarta .2009.107-124
22. Chapron C, Fauconnier A, Goffinet F, Breart G, Dubuisson JB. Laparoscopic
surgery is not inherently dangerous for patients presenting with benign
gynecologic

pathology:

results

of

a

meta-analysis.

Hum

Rep

rod2002;17:1334-42
23. Fritz, M.A., and Speroff, L. Clinical Gynecologic Endocrinology and Infertility:
Endometriosis. 8th edition. Lippincott Williams & Wilkins. North Caroline.
2011.1103-25
24. D’hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and
subfertility:

is

the

relationship

resolved?

Semin.

Reprod.

Med.

21(2).2003.243-254
25. Leyland N. Casper R, Laberge P, Sigh S S. Endometriosis: Diagnosis and
Management. Journal of Obstetrics and Gynaecology Canada. 2010 July; 32
(7)
26. Baldi A, Campioni M, and Signorile PG. Endometriosis: Pathogenesis,
diagnosis, therapy and association with cancer (review). Oncology Reports.
2008 Apr; 19 (4):p. 843-846
Universitas Sumatera Utara

Universitas Sumatera Utara

57

27. Overton C, Davis C, McMillan L, Shaw RW. An Atlas of Endometriosis. 3rd
ed. London: Informa Healthcare; 2007
28. Roberts, C.P., and Rock, J.A., 2003. The current staging system for
endometriosis: does it help?. Obstet Gynecol Clin N Am. 30(1):115– 132
29. llie R, llie I. The implication of Angiogenesis in Endometriosis. Biotechnology,
Molecular Biology and Nanomedicine. Vol. 2 No 1. 2014.341-8

30. Vigano P, Somigliana E, Panina P, Rabellotti, Vercellini P,Candiani M.
Principles of phenomics in endometriosis. Human Reproduction Update,
vol.18, no.3,2012.248-259
31. Bulun, S.E., 2009. Mechanism of Disease Endometriosis. N Eng J Med.
360(3): 268-279.
32. D'Hooghe TM, Nugent N, Cuneo S, et al. Recombinant human TNF binding
protein inhibits the development of endometriosis in baboons: a prospective,
randomized,

placebo

and

drug

controlled

study.

Biology

of

Reproduction.2006.74:131-136.
33. Siregar, HS.Role of L-Selectin Gene P213S Polymorphism and Macrophage
Profiles (M1,M2),2014. Vol 4, No 16.20-36
34.Sundqvist,

J.Pathophysiological

factors

and

genetic

association

in

endometriosis. Stockholm. Karolinska Institutet.2011.12-17
35. Lebovic, D. I., Mueller, M. D. and Taylor, R. N. Immunobiology of
endometriosis. Fertil Steril, 2001.75, 1-10.
36. Paul, D.W., and Braun, D.P. Immunology of endometriosis. Best Pract Res
Clin Obstet Gynaecol. Elsevier. 2004.18 (2):245-246

Universitas Sumatera Utara

Universitas Sumatera Utara

58

37. Valentine, J.E. Macrophage Involvement In The Remodelling Of An
Extracelluler Matrix Scaffold. B.S. in Materials Science and Engineering,
University of Florida.2009. 11-16
38. McCluggage WG. Immunohistochemical and Functional Biomarkers of Value
in Female Genital Tract Lesions. In : Robboy SJ, Mutter GL, et al editors.
Robboy’s Pathology of the Female Reproductive Tract. 2nd ed. China :
Churchill Livingstone Elsevier. 2009; 999-1002
39. Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, et al., 2010.

Polarization dictates iron handling by inflammatory and alternatively activated
macrophages. Haematologica.95(11):1814-1822

40.Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory microenvironment

in

tumor

progression:

the

role

of

tumor-associated

macrophages. Crit Rev Oncol Hematol. 2008. 66(1):1-9

41. Bacci, M., Capobianco, A., Monno, A., Cottone, L., Di Puppo, F., Camisa, B.,
et al. Macrophages Are Alternatively Activated in Patients with Endometriosis
and Required for Growth and Vascularization of Lesions in a Mouse Model of
Disease. Am J Pathol. 2008.175(2):547-556
42. Siregar HS. L-Selectin P213S Polymorphism and Macrophage Profils in
Endometriosis; an new insight into the Pathophysiology of Endometriosis.
Approved by Medan, Indonesia. Univ. of Sumatra Utara. 2014. Lambert
Academic Publishing, Schaltungsdients Lange o.H.G., Berlin.9-63.

Universitas Sumatera Utara

Universitas Sumatera Utara

59

43. Badylak, S.F., Valentin, J.E., Ravindra, A.K., McCabe, G.P., and StewartAkers, A.M. Macrophage Phenotype as a Determinant of Biologic Scaffold
Remodeling. Tissue Engineering Part A. 2008.14(11): 1835-1842.
44. Maghazachi AA.AI Aoukaty , Schall TJ. CC Chemokines Induce The
Generation of Killer Cells from CD 56+ Cells. J Immunol 26(2) 315-9
45. Donlon TA, Krenky AM, Wallace MR, Collins FS Lovett M.Clayberger C.
Choro T-cell-specific gene. RANTES to chromosome.1990.224-9
46. Aplin D J.Fazleabas A.Glasser SR.Giudice C linda. The Endometrium,
molecular, Cellular,and Clinical Perspectives. Second Edition.Departemen of
Obstetrics, Gynecology and Reproductive Sciences University of California
San Francisco,CA USA.2008 ;553-6
47. Borrelli GM. Abrao MS, Mechsner S. Can Chemokines be Used as
Biomarkers

for

Endometriosis?

A

Systematic

Review

Human

Reproduction.Brazil 2013; 1-14
48. Harada T.A Kaponis, Iwabe T.Taniguchi F, et all. Apoptosis in Human
Endometrium and Endometriosis. Human Reproduction Update.Vol 10.No
1.2004;29-38
49. Gupta, S., Agarwal, A., Sekhon, L., Krajcir, N., Cocuzza, M., and Falcone, T.
Serum and Peritoneal Abnormalities in Endometriosis: Potential Use As
Diagnostic Markers. Minerva Ginecol. 2006. 58(6):527-551
50. Bedaiwy MA,Falcone T.Laboratory testing for endometriosis.Clinica Chimica
Acta 2004.41-56
51. Viera AJ, Garrett JM. Understanding Interobserver Agreement:The Kappa
Statistic.Research series.University of North Carolina;vol.37,No.5.2005. 360363
Universitas Sumatera Utara

Universitas Sumatera Utara

60

52. Hurt KJ, Guile MW, et al. The John Hopkins Gynecology and Obstetric. 4th
edition, wolter kluwer, Baltimore Maryland, 2011; 448-453
53. Stoval DW. Clinical symptomatology of uterine leimyoma. Clin Obstet
Gynecol 2001; 44: 364-71
54. Hadibroto BR. Mioma Uteri. Departemen Obstetri dan Ginekologi, Fakultas
Kedokteran Universitas Sumatera Utara. Majalah Kedokteran Nusantara; vol
38, No.3.2005. 254-259
55. Astarto NW, Djuwantoto T, et al. Kupas tuntas Kelainan Haid, perlukah
pengangkatan mioma intramural pada gangguan haid serta infertilitas.
Bandung 2011: 228-240
56. Medikare V, Kandukuri LR, Ananthapur V, et al. The Genetic Bases of
Uterine Fibroid a review. J Reprod Infertil. 2011; 12(3): 181-191
57. Rogatto SR, Canevari RA: Uterine Leimyoma: Updates in Cytogenetics and
Molecular Analysis. Austral-Asian Journal. January 2007. (6): 16-18

Universitas Sumatera Utara

Universitas Sumatera Utara